-
Mashup Score: 2MSK’s Sloan Kettering Institute Celebrates 75 Years of Discovery - 11 month(s) ago
Over the last seven and a half decades, researchers at the Sloan Kettering Institute have made important contributions to the fundamental understanding of human biology, as well as driven practice-changing innovations in the treatment of cancer.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0July 12, 2023: International Precision Oncology Tumor Board: MSK & Sir HN Reliance Foundation Hospital: Targeting the BRAF Pathway - 11 month(s) ago
July 12, 2023: International Precision Oncology Tumor Board – Targeting the BRAF Pathway: MSK & Sir HN Reliance Foundation Hospital Interpreting results from next-generation genomic sequencing of cancer, and identifying the right drug for the right patient, is a challenge for many cancer specialists today. Join leading global experts for a new educational series from MSK, where we’ll take a deep…
Categories: Latest Headlines, Oncologists2Tweet-
Save the date! July 12, 2023: International Precision Oncology Tumor Board: MSK & Sir HN Reliance Foundation Hospital: Targeting BRAF Pathway @MSKCancerCenter @RFhospital @GianchandaniDr @Vijayharibhakti #DrMrinalGounder https://t.co/15IA8bzcrG
-
-
Mashup Score: 0Exposing a Cancer Cell’s Weakness - 11 month(s) ago
MSK has developed an arsenal of tests that are at the front lines of precision treatments. They target the structure of proteins that cause cancer, offering people new hope.
Categories: Latest Headlines, Oncologists2Tweet-
https://t.co/iWnhBcknG2. @MSKCancerCenter
-
-
Mashup Score: 8MSK’s Sloan Kettering Institute Celebrates 75 Years of Discovery - 11 month(s) ago
Over the last seven and a half decades, researchers at the Sloan Kettering Institute have made important contributions to the fundamental understanding of human biology, as well as driven practice-changing innovations in the treatment of cancer.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
👏Learn more about how our Sloan Kettering Institute researchers have made important contributions in the treatment of #cancer: https://t.co/B6yjFC9aio https://t.co/YmmPMG0qc2
-
-
Mashup Score: 6Cancer Podcast: Cancer Straight Talk from MSK - 11 month(s) ago
Cancer Straight Talk from MSK is a podcast about cancer that brings together patients and experts, to have straightforward evidence-based conversations. Memorial Sloan Kettering’s Dr. Diane Reidy-Lagunes hosts this cancer podcast with a mission to educate and empower cancer patients and their family members.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
On the latest episode of the Cancer Straight Talk from MSK podcast, we dive deep into the side effects of treatment: what they are, why they happen, and how to cope. Listen here: https://t.co/QghONpCqXF https://t.co/hX3Me0vc0a
-
-
Mashup Score: 2FDA Approves Teclistamab, a Promising New Drug for Multiple Myeloma Targeting BCMA and CD3 Proteins - 11 month(s) ago
Learn how FDA approval of a new multiple myeloma drug will brighten the outlook for people with resistant forms of the disease.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Read more about Dr. Usmani's work with #Teclistamab here. https://t.co/8yic5a7syg
-
-
Mashup Score: 2
Learn how researchers engineered CAR T cells to work better by using a mutation in a gene called c-KIT that drives cancer cell growth.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
A team led by MSK's Dr. Prasad Adusumilli created a way to boost #CARTcells’ power against solid tumors in lab studies by coopting a mutation in cancer cells. The findings are in @NatureCancer. https://t.co/m1DsWS2SUJ
-
-
Mashup Score: 15MSK-Led Research Finds Unexpected Link Between Chromosomal Instability and Epigenetic Alterations - 11 month(s) ago
MSK-led research found an unexpected link between chromosomal instability and epigenetic alternations, both of which are hallmarks of cancer — especially advanced, drug-resistant cancers.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
“I think this is a great example of a fundamental, basic science research discovery that will open multiple interesting avenues for exploration,” says chemical biologist Yael David of the @David_Lab_MSK. https://t.co/FJcrwfHpez
-
-
Mashup Score: 5Your Gut Microbiome: How To Improve It, Its Effects on the Immune System, and More - 11 month(s) ago
In this story, an expert in the gut microbiome answers common questions about how your gut microbiota impacts your health, how to protect it, and the impact it has on diseases like cancer.
Categories: Hem/Oncs, Latest HeadlinesTweet-
RT @DrMvandenBrink: Your Gut Microbiome: How To Improve It, Its Effects on the Immune System, and More https://t.co/A6AKF5SQAF
-
-
Mashup Score: 5Targeted Therapy Delays Growth for IDH-Mutant Glioma - 11 month(s) ago
Neuro-oncologist Ingo Mellinghoff, MD, FACP discusses how his research has led to a new targeted therapy for IDH-mutant glioma – and details how this may mark a paradigm shift in therapeutic options for patients with brain tumors.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🔬 Important research on #WorldBrainTumorDay: Neuro-oncologist Dr. Ingo Mellinghoff shares how his research has led to a new targeted therapy for IDH-mutant glioma – potentially creating a paradigm shift in therapeutic options for patients w/#braintumors. https://t.co/HhqWHNVkpm
-
Learn more here: https://t.co/B6yjFC9aio